CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Karyn Foster

OPENALEX: A5028084787↗ORCID: 0000-0002-7525-1547↗

Affiliations

Organizations

Mater Researchauthorship · AU The University of Queenslandauthorship · AU

Public evidence

1 connected articles

Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.2024 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Karyn Foster - Medical Cannabis Research Engine